UTEK agrees to assist Human BioSystems in expanding opportunities for its preservation technology

By Lisa Kerner

Charlotte, N.C., Aug. 15 - Human BioSystems and UTEK Corp. signed an agreement that will assist Human BioSystems in its efforts to reach out to potential business partners regarding its preservation technology, including above-zero and below-zero preservation technology for organs and other biomaterials, as well as a blood platelet preservation process.

Human BioSystems plans to market its preservation technologies worldwide, including a number of markets in the United States.

"When we license a technology, we can segment and limit the license to a particular application, an example being the preservation of donor organs while excluding the application for islet cells," Human BioSystems chief executive Harry Masuda said in a company news release.

"In other words, licensing will not preclude us from entering non-licensed markets or activities," Masuda added.

Based in Palo Alto, Calif., Human BioSystems develops of preservation platforms for organs and other biomaterials.

UTEK is a technology transfer company based in Plant City, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.